An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness

Sponsor
Technische Universität Dresden (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00180232
Collaborator
(none)
0
1
2
0

Study Details

Study Description

Brief Summary

The study tries to reveal if aminobisphosphonates influence aside the bone density also the vascular status in the typical elderly patient population

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The subjects - starting bisphosphonate treatment due to medical reasons - will be additionally investigated as outpatients (arterial stiffness, applanation tonometry), for each subject 3 individual dates with a duration of approx. 30 min each are scheduled, prior to therapy with bisphosphonate, after 3 and 6 month of treatment

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    0 participants
    Time Perspective:
    Prospective
    Official Title:
    An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness (Changes of the Aortal Elasticity Due to a Newly Established Aminobiphosphinate Therapy for the Treatment of Osteoporosis)
    Study Start Date :
    Apr 1, 2006
    Actual Study Completion Date :
    Jun 1, 2006

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Patients starting an aminobisphosphonate therapy due to medical reasons Broca-index: between -20 and +25% who are willing and capable to confirm written consent to enrolment after ample information has been provided

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • Patients starting an aminobisphosphonate therapy due to medical reasons Broca-index: between -20 and +25% who are willing and capable to confirm written consent to enrolment after ample information has been provided
      Exclusion Criteria:
      • patients with major cardiovascular disease patients participating in another clinical trial 1month prior to inclusion in this study patients unable or unwilling to give informed consent

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Medizinische Fakultät der Technischen Universität Dresden Dresden Germany 01307

      Sponsors and Collaborators

      • Technische Universität Dresden

      Investigators

      • Principal Investigator: Joachim Siegert, MDDPharm,Phd, Technische Universität Dresden

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00180232
      Other Study ID Numbers:
      • EK160082004
      First Posted:
      Sep 16, 2005
      Last Update Posted:
      Feb 3, 2012
      Last Verified:
      Feb 1, 2012
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Feb 3, 2012